Firmenbeschreibung
Amgen Inc. zählt weltweit zu den führenden Biotech-Unternehmen. Amgen entwickelt, produziert und vertreibt biopharmazeutische Produkte, die mit Hilfe rekombinanter DNA-Technologien hergestellt werden. Die Forschungsschwerpunkte sind dabei die Hämatologie (Wissenschaft der Blutkrankheiten), Onkologie (Krebsforschung), Nephrologie (Wissenschaft der Nierenkrankheiten), Rheumatologie, Diabetes, Endokrinologie (Lehre der inneren Sekretionsdrüsen), Neurologie und Zelltherapie.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Vanguard Group, Inc. (9.14%),Blackrock Inc. (9.13%),State Street Corporation (5.46%),Primecap Management Company (2.83%),Morgan Stanley (2.4%),Capital Research Global Investors (2.21%),Geode Capital Management, LLC (2.14%),Charles Schwab Investment Management, Inc. (2.01%),Wells Fargo & Company (1.42%),Northern Trust Corporation (1.3%) |
| sharesOutstanding: | 535918901.0000 |
| ceo: | Robert Bradway |
| board: | Peter H. Griffith, Annalisa Pizzarello, Anton Rabushka, Arleen Paulino, Darryl Sleep, David A. Piacquad, David M. Reese, Esteban Santos, Gilles Marrache, Ian Thompson, Jean-Charles Soria, Jerry Murry, Jonathan Graham, Judy Gawlik Brown, Lori Johnston, Mark J. Taisey, Mike Zahigian, Murdo Gordon, Nancy Grygiel, Rachna Khosla, Raymond Deshaies, Rob Lenz, Susan Sweeney, Victoria H. Blatter |
| supervisoryBoard: | Robert A. Bradway, Amy E. Miles, Brian J. Druker, Charles M. Holley Jr., Ellen J. Kullman, Greg C. Garland, Michael V. Drake, R. Sanders Williams, Robert A. Eckert, Ronald D. Sugar, S. Omar Ishrak, Tyler Jacks, Wanda M. Austin |
| countryID: | 20 |
| freeFloat: | 76.2000 |
| faceValue: | 0.0001 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Medizintechnische Produkte |
| industryName: | Gesundheitswesen |
| subsectorName: | Hochentwickelte medizinische Geräte |
| country: | USA |
| countryName: | USA |
Kontakt
| phone: | +1-805-447-1060 |
| email: | investor.relations@amgen.com |
| irWebSite: | investors.amgen.com |
Adresse
| street: | One Amgen Center Drive |
| city: | Thousand Oaks, CA 91320-1799, USA |
| phone: | +1-805-447-1000 |
| fax: | +1-805-447-1010 |
| webSite: | www.amgen.com |
| email: | investor.relations@amgen.com |
Finanzen (kurz)
| year: | 2021 | cash: | 7989.0000 |
| balanceSheetTotal: | 61165.0000 | liabilities: | 54465.0000 |
| totalShareholdersEquity: | 6700.0000 | sales: | 25979.0000 |
| bankLoans: | 7639.0000 | investment: | 259.0000 |
| incomeBeforeTaxes: | 6701.0000 | netIncome: | 5893.0000 |
| cashFlow: | 1723.0000 | employees: | 24200 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2022 | cash: | 7629.0000 |
| balanceSheetTotal: | 65121.0000 | liabilities: | 61460.0000 |
| totalShareholdersEquity: | 3661.0000 | sales: | 26323.0000 |
| incomeBeforeTaxes: | 7346.0000 | netIncome: | 6552.0000 |
| cashFlow: | -360.0000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2023 | cash: | 10944.0000 |
| balanceSheetTotal: | 97154.0000 | liabilities: | 90922.0000 |
| totalShareholdersEquity: | 6232.0000 | sales: | 28190.0000 |
| incomeBeforeTaxes: | 7855.0000 | netIncome: | 6717.0000 |
| cashFlow: | 3315.0000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 7989.0000 |
| balanceSheetTotal: | 61165.0000 |
| liabilities: | 54465.0000 |
| totalShareholdersEquity: | 6700.0000 |
| sales: | 25979.0000 |
| bankLoans: | 7639.0000 |
| investment: | 259.0000 |
| incomeBeforeTaxes: | 6701.0000 |
| netIncome: | 5893.0000 |
| cashFlow: | 1723.0000 |
| employees: | 24200 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 7629.0000 |
| balanceSheetTotal: | 65121.0000 |
| liabilities: | 61460.0000 |
| totalShareholdersEquity: | 3661.0000 |
| sales: | 26323.0000 |
| incomeBeforeTaxes: | 7346.0000 |
| netIncome: | 6552.0000 |
| cashFlow: | -360.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 10944.0000 |
| balanceSheetTotal: | 97154.0000 |
| liabilities: | 90922.0000 |
| totalShareholdersEquity: | 6232.0000 |
| sales: | 28190.0000 |
| incomeBeforeTaxes: | 7855.0000 |
| netIncome: | 6717.0000 |
| cashFlow: | 3315.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 65121.0000 | cash: | 7629.0000 |
| currentAssets: | 22186.0000 | fixedAssets: | 42935.0000 |
| liabilities: | 15687.0000 | totalLiabilitiesEquity: | 65121.0000 |
| totalShareholdersEquity: | 3661.0000 | property: | 5427.0000 |
| intangibleAssets: | 16080.0000 | inventories: | 4930.0000 |
| accountsReceivable: | 5563.0000 | accountsPayable: | 1572.0000 |
| liabilitiesTotal: | 61460.0000 | longTermDebt: | 37354.0000 |
| shortTermDebt: | 1591.0000 | sales: | 26323.0000 |
| depreciation: | 3417.0000 | netIncome: | 6552.0000 |
| operatingResult: | 9566.0000 | incomeInterest: | -1406.0000 |
| investments: | 4434.0000 | incomeTaxes: | 794.0000 |
| costGoodsSold: | 6406.0000 | grossProfit: | 19917.0000 |
| cashFlow: | 9721.0000 | cashFlowInvesting: | -6044.0000 |
| cashFlowFinancing: | -4037.0000 | cashFlowTotal: | -360.0000 |
| accountingStandard: | US GAAP | equityRatio: | 5.6218 |
| debtEquityRatio: | 1678.7763 | liquidityI: | 48.6326 |
| liquidityII: | 84.0951 | netMargin: | 24.8908 |
| grossMargin: | 75.6639 | cashFlowMargin: | 36.9297 |
| ebitMargin: | 36.3408 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 200.6556 | preTaxROA: | 11.2805 |
| roe: | 178.9675 | roa: | 10.0613 |
| netIncomeGrowth: | 11.1828 | revenuesGrowth: | 1.3241 |
| taxExpenseRate: | 10.8086 | equityTurnover: | 7.1901 |
| epsBasic: | 12.1800 | epsDiluted: | 12.1100 |
| epsBasicGrowth: | 17.7950 | incomeBeforeTaxes: | 7346.0000 |
| priceEarningsRatioCompany: | 21.5632 | priceCashFlowRatio: | 14.4269 |
| dividendYield: | 3.0270 | bookValuePerShare: | 6.8561 |
| marketCap: | 140243519148.3200 | earningsYield: | 4.6375 |
| pegRatio: | 1.2118 | cashFlowPerShare: | 18.2049 |
| priceBookValueRatio: | 38.3074 | dividendsPerShare: | 7.9500 |
| priceEarningsRatio: | 21.4047 | netEarningsPerShare: | 12.2702 |
| currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 97154.0000 | cash: | 10944.0000 |
| currentAssets: | 30332.0000 | fixedAssets: | 66822.0000 |
| liabilities: | 18392.0000 | totalLiabilitiesEquity: | 97154.0000 |
| totalShareholdersEquity: | 6232.0000 | property: | 5941.0000 |
| intangibleAssets: | 32641.0000 | inventories: | 9518.0000 |
| accountsReceivable: | 7268.0000 | accountsPayable: | 1590.0000 |
| liabilitiesTotal: | 90922.0000 | longTermDebt: | 63170.0000 |
| shortTermDebt: | 1443.0000 | sales: | 28190.0000 |
| depreciation: | 4071.0000 | netIncome: | 6717.0000 |
| operatingResult: | 7897.0000 | incomeInterest: | -2875.0000 |
| investments: | 4784.0000 | incomeTaxes: | 1138.0000 |
| costGoodsSold: | 8451.0000 | grossProfit: | 19739.0000 |
| cashFlow: | 8471.0000 | cashFlowInvesting: | -26204.0000 |
| cashFlowFinancing: | 21048.0000 | cashFlowTotal: | 3315.0000 |
| accountingStandard: | US GAAP | equityRatio: | 6.4146 |
| debtEquityRatio: | 1458.9538 | liquidityI: | 59.5041 |
| liquidityII: | 99.0213 | netMargin: | 23.8276 |
| grossMargin: | 70.0213 | cashFlowMargin: | 30.0497 |
| ebitMargin: | 28.0135 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 126.0430 | preTaxROA: | 8.0851 |
| roe: | 107.7824 | roa: | 6.9138 |
| netIncomeGrowth: | 2.5183 | revenuesGrowth: | 7.0927 |
| taxExpenseRate: | 14.4876 | equityTurnover: | 4.5234 |
| epsBasic: | 12.5600 | epsDiluted: | 12.4900 |
| epsBasicGrowth: | 3.1199 | incomeBeforeTaxes: | 7855.0000 |
| priceEarningsRatioCompany: | 22.9315 | priceCashFlowRatio: | 18.2216 |
| dividendYield: | 2.9998 | bookValuePerShare: | 11.6286 |
| marketCap: | 154355361866.0200 | earningsYield: | 4.3608 |
| pegRatio: | 7.3502 | cashFlowPerShare: | 15.8065 |
| priceBookValueRatio: | 24.7682 | dividendsPerShare: | 8.6400 |
| priceEarningsRatio: | 22.9798 | netEarningsPerShare: | 12.5336 |
| currency: | USD |
| year: | 2024 | priceEarningsRatioCompany: | 21.4116 |
| priceCashFlowRatio: | 17.0139 | dividendYield: | 3.2127 |
| bookValuePerShare: | 11.6286 | marketCap: | 144124670045.9300 |
| earningsYield: | 4.6704 | pegRatio: | 6.8630 |
| cashFlowPerShare: | 15.8065 | netAssetsPerShare: | 11.6286 |
| priceBookValueRatio: | 23.1266 | priceEarningsRatio: | 21.4567 |
| netEarningsPerShare: | 12.5336 | currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 65121.0000 |
| cash: | 7629.0000 |
| currentAssets: | 22186.0000 |
| fixedAssets: | 42935.0000 |
| liabilities: | 15687.0000 |
| totalLiabilitiesEquity: | 65121.0000 |
| totalShareholdersEquity: | 3661.0000 |
| property: | 5427.0000 |
| intangibleAssets: | 16080.0000 |
| inventories: | 4930.0000 |
| accountsReceivable: | 5563.0000 |
| accountsPayable: | 1572.0000 |
| liabilitiesTotal: | 61460.0000 |
| longTermDebt: | 37354.0000 |
| shortTermDebt: | 1591.0000 |
| sales: | 26323.0000 |
| depreciation: | 3417.0000 |
| netIncome: | 6552.0000 |
| operatingResult: | 9566.0000 |
| incomeInterest: | -1406.0000 |
| investments: | 4434.0000 |
| incomeTaxes: | 794.0000 |
| costGoodsSold: | 6406.0000 |
| grossProfit: | 19917.0000 |
| cashFlow: | 9721.0000 |
| cashFlowInvesting: | -6044.0000 |
| cashFlowFinancing: | -4037.0000 |
| cashFlowTotal: | -360.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 5.6218 |
| debtEquityRatio: | 1678.7763 |
| liquidityI: | 48.6326 |
| liquidityII: | 84.0951 |
| netMargin: | 24.8908 |
| grossMargin: | 75.6639 |
| cashFlowMargin: | 36.9297 |
| ebitMargin: | 36.3408 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 200.6556 |
| preTaxROA: | 11.2805 |
| roe: | 178.9675 |
| roa: | 10.0613 |
| netIncomeGrowth: | 11.1828 |
| revenuesGrowth: | 1.3241 |
| taxExpenseRate: | 10.8086 |
| equityTurnover: | 7.1901 |
| epsBasic: | 12.1800 |
| epsDiluted: | 12.1100 |
| epsBasicGrowth: | 17.7950 |
| incomeBeforeTaxes: | 7346.0000 |
| priceEarningsRatioCompany: | 21.5632 |
| priceCashFlowRatio: | 14.4269 |
| dividendYield: | 3.0270 |
| bookValuePerShare: | 6.8561 |
| marketCap: | 140243519148.3200 |
| earningsYield: | 4.6375 |
| pegRatio: | 1.2118 |
| cashFlowPerShare: | 18.2049 |
| priceBookValueRatio: | 38.3074 |
| dividendsPerShare: | 7.9500 |
| priceEarningsRatio: | 21.4047 |
| netEarningsPerShare: | 12.2702 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 97154.0000 |
| cash: | 10944.0000 |
| currentAssets: | 30332.0000 |
| fixedAssets: | 66822.0000 |
| liabilities: | 18392.0000 |
| totalLiabilitiesEquity: | 97154.0000 |
| totalShareholdersEquity: | 6232.0000 |
| property: | 5941.0000 |
| intangibleAssets: | 32641.0000 |
| inventories: | 9518.0000 |
| accountsReceivable: | 7268.0000 |
| accountsPayable: | 1590.0000 |
| liabilitiesTotal: | 90922.0000 |
| longTermDebt: | 63170.0000 |
| shortTermDebt: | 1443.0000 |
| sales: | 28190.0000 |
| depreciation: | 4071.0000 |
| netIncome: | 6717.0000 |
| operatingResult: | 7897.0000 |
| incomeInterest: | -2875.0000 |
| investments: | 4784.0000 |
| incomeTaxes: | 1138.0000 |
| costGoodsSold: | 8451.0000 |
| grossProfit: | 19739.0000 |
| cashFlow: | 8471.0000 |
| cashFlowInvesting: | -26204.0000 |
| cashFlowFinancing: | 21048.0000 |
| cashFlowTotal: | 3315.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 6.4146 |
| debtEquityRatio: | 1458.9538 |
| liquidityI: | 59.5041 |
| liquidityII: | 99.0213 |
| netMargin: | 23.8276 |
| grossMargin: | 70.0213 |
| cashFlowMargin: | 30.0497 |
| ebitMargin: | 28.0135 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 126.0430 |
| preTaxROA: | 8.0851 |
| roe: | 107.7824 |
| roa: | 6.9138 |
| netIncomeGrowth: | 2.5183 |
| revenuesGrowth: | 7.0927 |
| taxExpenseRate: | 14.4876 |
| equityTurnover: | 4.5234 |
| epsBasic: | 12.5600 |
| epsDiluted: | 12.4900 |
| epsBasicGrowth: | 3.1199 |
| incomeBeforeTaxes: | 7855.0000 |
| priceEarningsRatioCompany: | 22.9315 |
| priceCashFlowRatio: | 18.2216 |
| dividendYield: | 2.9998 |
| bookValuePerShare: | 11.6286 |
| marketCap: | 154355361866.0200 |
| earningsYield: | 4.3608 |
| pegRatio: | 7.3502 |
| cashFlowPerShare: | 15.8065 |
| priceBookValueRatio: | 24.7682 |
| dividendsPerShare: | 8.6400 |
| priceEarningsRatio: | 22.9798 |
| netEarningsPerShare: | 12.5336 |
| currency: | USD |
| year: | 2024 |
| priceEarningsRatioCompany: | 21.4116 |
| priceCashFlowRatio: | 17.0139 |
| dividendYield: | 3.2127 |
| bookValuePerShare: | 11.6286 |
| marketCap: | 144124670045.9300 |
| earningsYield: | 4.6704 |
| pegRatio: | 6.8630 |
| cashFlowPerShare: | 15.8065 |
| netAssetsPerShare: | 11.6286 |
| priceBookValueRatio: | 23.1266 |
| priceEarningsRatio: | 21.4567 |
| netEarningsPerShare: | 12.5336 |
| currency: | USD |
